| JYSB2000696 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-03-17 | view |
| JXSL1300034 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2013-05-23 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-08-10 | view |
| JXSL1800044 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-10-29 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2018-10-26 | view |
| JYSB2000386 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-02 | view |
| JYSB1900363 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-01-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-03-24 | view |
| JXSL1200073 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2012-12-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2014-02-07 | view |
| JYSB1800226 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2018-10-26 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-12-19 | view |
| JYSB2000140 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-05-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-01 | view |
| JYSB1900081 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2019-04-11 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-12-13 | view |
| JYSB2000662 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-12-24 | view |
| JXSS1800020 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-09-29 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-08-20 | view |
| JYSB2000079 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-07-16 | view |
| JYSB2000601 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-12-17 | view |
| JYSB2000034 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-02-10 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-02-18 | view |
| JXSL1300083 | 帕妥珠单抗 | pertuzumab | Injection | Biological Products | Import Drug Application | 2014-01-03 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2015-10-19 | view |
| JXSS1800042 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2019-01-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2019-12-12 | view |
| JYSB2000387 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-10-15 | view |
| JYSB1800185 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2018-08-30 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2018-12-19 | view |
| CXSL1700090 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(2) | New Drug Application | 2017-10-18 | 正大天晴药业集团南京顺欣制药有限公司 | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | Certificate Issued | 2018-05-08 | view |
| JXSS1700018 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-01-02 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2018-12-19 | view |
